Article

Ibuprofen Can Help Bleeding Risk After Plastic Surgery

Author(s):

Patients have often been told to avoid ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) before or after surgery due to an increased risk of bleeding.

Patients have often been told to avoid ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) before or after surgery due to an increased risk of bleeding.

However, new evidence suggests ibuprofen does not in fact increase the risk of bleeding following plastic surgery procedures.

Researchers from the University of Michigan believed ibuprofen could provide safe and effective pain control for selected plastic surgery procedures, while avoiding the higher risks and costs of some other pain medications.

To compare ibuprofen with other pain medications for patients undergoing plastic surgery-related operations, the research team conducted a systemic review of four studies in which 443 patients were randomly assigned to receive ibuprofen or other medications such as acetaminophen, acetaminophen plus codeine, or the prescription-only NSAID ketorolac.

The procedures that were studied included cosmetic facial surgery, breast cancer surgery, hernia repair, and skin cancer surgery and reconstruction.

All the studies began ibuprofen administration of 400 mg every four hours either before or immediately after surgery and continued for at least one week.

Findings reported good pain control across study medications. Ibuprofen and the other treatments also showed similar bleeding risks. The rates of “surgically significant postoperative bleeding” were 3.5% with ibuprofen and 4.1% with other treatments.

The researchers did acknowledge their study was limited to procedures were bleeding and hematomas were easily traceable.

Nonetheless, the team believed for plastic and dermatological surgery procedures for smaller areas, ibuprofen could provide good pain control without increasing the risk of bleeding.

The authors concluded, “OTC analgesics like ibuprofen are more cost effective given their effectiveness in pain control, well-established public tolerance, and low-risk qualities for abuse.”

Related Videos
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD
2 Additional Clinical Pearls for Dermatologists, with Eingun James Song, MD
2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD
What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
© 2024 MJH Life Sciences

All rights reserved.